These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 33618829)

  • 1. Quinolines, a perpetual, multipurpose scaffold in medicinal chemistry.
    Yadav P; Shah K
    Bioorg Chem; 2021 Apr; 109():104639. PubMed ID: 33618829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinoline: An Attractive Scaffold in Drug Design.
    Moor LFE; Vasconcelos TRA; da R Reis R; Pinto LSS; da Costa TM
    Mini Rev Med Chem; 2021; 21(16):2209-2226. PubMed ID: 33568032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicinal chemistry of indole derivatives: Current to future therapeutic prospectives.
    Kumari A; Singh RK
    Bioorg Chem; 2019 Aug; 89():103021. PubMed ID: 31176854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of quinoline as a privileged scaffold in cancer drug discovery.
    Musiol R
    Expert Opin Drug Discov; 2017 Jun; 12(6):583-597. PubMed ID: 28399679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of novel pyrazolo[3,4-d]pyrimidin-4-one bearing quinoline scaffold as potent dual PDE5 inhibitors and apoptotic inducers for cancer therapy.
    Ibrahim TS; Hawwas MM; Taher ES; Alhakamy NA; Alfaleh MA; Elagawany M; Elgendy B; Zayed GM; Mohamed MFA; Abdel-Samii ZK; Elshaier YAMM
    Bioorg Chem; 2020 Dec; 105():104352. PubMed ID: 33080494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review on anticancer potential of bioactive heterocycle quinoline.
    Afzal O; Kumar S; Haider MR; Ali MR; Kumar R; Jaggi M; Bawa S
    Eur J Med Chem; 2015 Jun; 97():871-910. PubMed ID: 25073919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinoline as a privileged scaffold in cancer drug discovery.
    Solomon VR; Lee H
    Curr Med Chem; 2011; 18(10):1488-508. PubMed ID: 21428893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and biological survey of 7-chloro-4-(piperazin-1-yl)quinoline and its derivatives.
    El-Azzouny AMAE; Aboul-Enein MN; Hamissa MF
    Drug Dev Res; 2020 Nov; 81(7):786-802. PubMed ID: 32385857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinoline Derivatives as Promising Scaffolds for Antitubercular Activity: A Comprehensive Review.
    Owais M; Kumar A; Hasan SM; Singh K; Azad I; Hussain A; Suvaiv ; Akil M
    Mini Rev Med Chem; 2024; 24(13):1238-1251. PubMed ID: 38185891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent update on antibacterial and antifungal activity of quinoline scaffolds.
    Dorababu A
    Arch Pharm (Weinheim); 2021 Mar; 354(3):e2000232. PubMed ID: 33210348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression and expansion of quinoline as bioactive moiety: a patent review.
    Chauhan Y; Neha K; Wakode S; Shahfaiz M; Bodla RB; Sharma K
    Pharm Pat Anal; 2023 Nov; 12(6):287-314. PubMed ID: 38294336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Overview of Privileged Scaffold: Quinolines and Isoquinolines in Medicinal Chemistry as Anticancer Agents.
    Mao Y; Soni K; Sangani C; Yao Y
    Curr Top Med Chem; 2020; 20(28):2599-2633. PubMed ID: 32942976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular design and synthesis of certain new quinoline derivatives having potential anticancer activity.
    Ibrahim DA; Abou El Ella DA; El-Motwally AM; Aly RM
    Eur J Med Chem; 2015 Sep; 102():115-31. PubMed ID: 26256032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel quinoline-3-carboxamides (Part 2): Design, optimization and synthesis of quinoline based scaffold as EGFR inhibitors with potent anticancer activity.
    Aly RM; Serya RAT; El-Motwally AM; Esmat A; Abbas S; Abou El Ella DA
    Bioorg Chem; 2017 Dec; 75():368-392. PubMed ID: 29096097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive review on the biological interest of quinoline and its derivatives.
    Matada BS; Pattanashettar R; Yernale NG
    Bioorg Med Chem; 2021 Feb; 32():115973. PubMed ID: 33444846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic significance of quinolines: a patent review (2013-2015).
    Hussaini SM
    Expert Opin Ther Pat; 2016 Oct; 26(10):1201-21. PubMed ID: 27458877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA Fragmentation, Cell Cycle Arrest, and Docking Study of Novel Bis Spiro-cyclic 2-oxindole of Pyrimido[4,5-b]quinoline-4,6-dione Derivatives Against Breast Carcinoma.
    Mohamed MF; Abdelmoniem AM; Elwahy AHM; Abdelhamid IA
    Curr Cancer Drug Targets; 2018; 18(4):372-381. PubMed ID: 28669339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational and Synthetic approach with Biological Evaluation of Substituted Quinoline derivatives as small molecule L858R/T790M/C797S triple mutant EGFR inhibitors targeting resistance in Non-Small Cell Lung Cancer (NSCLC).
    Karnik KS; Sarkate AP; Tiwari SV; Azad R; Burra PVLS; Wakte PS
    Bioorg Chem; 2021 Feb; 107():104612. PubMed ID: 33476869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent contributions of quinolines to antimalarial and anticancer drug discovery research.
    Van de Walle T; Cools L; Mangelinckx S; D'hooghe M
    Eur J Med Chem; 2021 Dec; 226():113865. PubMed ID: 34655985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of quinoline-chalcones and heterocyclic chalcone-appended quinolines as broad-spectrum pharmacological agents.
    Atukuri D; S V; R S; L V; R P; M M R
    Bioorg Chem; 2020 Dec; 105():104419. PubMed ID: 33142228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.